Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CD55

CD55

Brief Information

Name:Complement decay-accelerating factor
Target Synonym:DAF,Complement decay-accelerating factor,CD55,CD55 Molecule (Cromer Blood Group),CD55 Molecule, Decay Accelerating Factor For Complement (Cromer Blood Group),CD55 Antigen,CR,Decay Accelerating Factor For Complement (CD55, Cromer Blood Group System),Cromer Blood Group Antigen,CHAPLE,CROM,TC,CD55 Antigens
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
CD5-H5225 Human Human CD55 / DAF Protein, His Tag
CD5-H5225-structure
CD5-H5225-sds
ACRO Quality

Synonym Name

CD55,DAF,CR,CROM,TC

Background

CD55 is also

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Gebasaxturev V-937; CVA-21 Phase 2 Clinical Viralytics Ltd Head and Neck Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms; Breast Neoplasms; Prostatic Neoplasms; Neoplasm Metastasis; Melanoma Details
Recombinant coxsackievirus B3 Phase 1 Clinical Wuhan Boweid Biotechnology Co Ltd Neoplasms Details
PAT-SC1 SC-1; PAT-SC1; PAT-SC-1 Phase 2 Clinical Oncomab Gmbh Stomach Neoplasms Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message